The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Sonam Gurung und 40 weiteren Autor:innen. Beteiligte Einrichtung: Great Ormond Street Institute of Child Health, University College London, London, UK. Hauptthemen laut MEDLINE: Argininosuccinic Aciduria, Movement Disorders, Neuroimaging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, United Kingdom Medical Research Council Clinician Scientist Fellowship, NIHR Great Ormond Street Hospital Biomedical Research Centre.
Abstract (Originalsprache)
Argininosuccinate lyase (ASL) is integral to the urea cycle detoxifying neurotoxic ammonia and the nitric oxide (NO) biosynthesis cycle. Inherited ASL deficiency causes argininosuccinic aciduria (ASA), a rare disease with hyperammonemia and NO deficiency. Patients present with developmental delay, epilepsy and movement disorder, associated with NO‐mediated downregulation of central catecholamine biosynthesis. A neurodegenerative phenotype has been proposed in ASA. To better characterise this neurodegenerative phenotype in ASA, we conducted a retrospective study in six paediatric and adult metabolic centres in the UK in 2022. We identified 60 patients and specifically looked for neurodegeneration‐related symptoms: movement disorder such as ataxia, tremor and dystonia, hypotonia/fatigue and abnormal behaviour. We analysed neuroimaging with diffusion tensor imaging (DTI) magnetic resonance imaging (MRI) in an individual with ASA with movement disorders. We assessed conventional and DTI MRI alongside single photon emission computer tomography (SPECT) with dopamine analogue radionuclide 123 I‐ioflupane, in Asl ‐deficient mice treated by hASL mRNA with normalised ureagenesis. Movement disorders in ASA appear in the second and third decades of life, becoming more prevalent with ageing and independent from the age of onset of hyperammonemia. Neuroimaging can show abnormal DTI features affecting both grey and white matter, preferentially basal ganglia. ASA mouse model with normalised ureagenesis did not recapitulate these DTI findings and showed normal 123 I‐ioflupane SPECT and cerebral dopamine metabolomics. Altogether these findings support the pathophysiology of a late‐onset movement disorder with cell‐autonomous functional central catecholamine dysregulation but without or limited neurodegeneration of dopaminergic neurons, making these symptoms amenable to targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Great Ormond Street Institute of Child Health, University College London, London, UK.
- Centre for Advanced Biomedical Imaging, University College London, London, UK.
- Great Ormond Street Hospital for Children NHS Trust, London, UK.
- Department of Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
- Mark Holland Metabolic Unit, Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford, UK.
- Willink Unit, Manchester Centre for Genomic Medicine, Manchester, UK.
ORCID-Profile: Julien Baruteau
Förderung
- Medical Research Council
- United Kingdom Medical Research Council Clinician Scientist Fellowship
- NIHR Great Ormond Street Hospital Biomedical Research Centre
- Moderna Therapeutics
- Moderna
Zitieren
APA
Gurung, S., Karamched, S., Perocheau, D., Seunarine, K. K., Baldwin, T., Alrashidi, H., Touramanidou, L., Duff, C., Elkhateeb, N., Stepien, K. M., Sharma, R., Morris, A., Hartley, T., Crowther, L., Grunewald, S., Cleary, M., Mundy, H., Chakrapani, A., Batzios, S., …, & Baruteau, J. (2024). The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12691
Vancouver
Gurung S, Karamched S, Perocheau D, Seunarine KK, Baldwin T, Alrashidi H, et al. The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12691
BibTeX
@article{Gurung2024,
author = {Gurung, Sonam and Karamched, Saketh and Perocheau, Dany and Seunarine, Kiran K and Baldwin, Tom and Alrashidi, Haya and Touramanidou, Loukia and Duff, Claire and Elkhateeb, Nour and Stepien, Karolina M and Sharma, Reena and Morris, Andrew and Hartley, Thomas and Crowther, Laura and Grunewald, Stephanie and Cleary, Maureen and Mundy, Helen and Chakrapani, Anupam and Batzios, Spyros and Davison, James and Footitt, Emma and Tuschl, Karin and Lachmann, Robin and Murphy, Elaine and Santra, Saikat and Uudelepp, Mari-Liis and Yeo, Mildrid and Finn, Patrick F and Cavedon, Alex and Siddiqui, Summar and Rice, Lisa and Martini, Paolo G V and Frassetto, Andrea and Heales, Simon and Mills, Philippa B and Gissen, Paul and Clayden, Jonathan D and Clark, Christopher A and Eaton, Simon and Kalber, Tammy L and Baruteau, Julien},
title = {The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12691}
}
EUVIMED